Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events (MACE) ...
Mar 12, 2018
0
5
The anti-cholesterol drug Praluent (alirocumab), made by France's Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study said Saturday.
Mar 10, 2018
0
86
As heart month kicks off, doctors at Baylor College of Medicine say the first step to taking control of your health and preventing cardiovascular disease is understanding the basics and what they represent for your heart.
Feb 2, 2018
0
9
Heart disease stubbornly remains one of the biggest killers in the UK, where there are 7m people living with the condition. During the past 60 years, the management of cholesterol has become an important weapon in the fight ...
Jan 26, 2018
1
50
(HealthDay)—For patients with autosomal recessive hypercholesterolemia (ARH), low-density lipoprotein cholesterol (LDL-C) levels remain high despite intensive treatment, according to a study published in the Jan. 23 issue ...
Jan 19, 2018
0
2
The use of camelina oil reduces overall and LDL cholesterol levels in persons with impaired glucose metabolism, according to a new study from the University of Eastern Finland. The findings were published in Molecular Nutrition ...
Jan 8, 2018
0
3
Cinnamon is a popular spice at Christmas time, used to flavour everything from mulled wine to pumpkin pie. And, unlike many Christmas foods, this one might actually be good for you.
Dec 22, 2017
0
19
Half of middle-aged people who are normal weight and don't smoke or have diabetes may have clogged arteries, researchers said Thursday, urging stronger measures to lower cholesterol.
Dec 11, 2017
0
185
LDL cholesterol (LDL-C), known as 'bad' cholesterol, is the underlying reason why many apparently healthy individuals have heart attacks or strokes during middle age despite not having cardiovascular risk factors such as ...
Dec 11, 2017
0
49
(HealthDay)—Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) may help assess apparent resistance to PCSK9 inhibitors, according to a research letter published online Nov. 28 in the Annals of Internal ...
Nov 29, 2017
0
19
